Martin E. Wohlfahrt

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index1.5kcitations25works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(13), CRISPR and Genetic Engineering(9), RNA Interference and Gene Delivery(8), CAR-T cell therapy research(7), Pluripotent Stem Cells Research(4)

Publications25 total

Genomic architecture of seed weight and progeny germination under contrasting maternal environments in common bean
Epsilon Archive for Student Projects (University of Southampton)·2025Open Access
232 Increased potency and functional persistence <i>in vitro</i> of a next-generation NY-ESO-1-specific TCR therapy incorporating Gen-R™ genetic reprogramming technology
Regular and Young Investigator Award Abstracts·2022Open Access
Abstract 2754: LYL797, a ROR1 CAR T-cell therapy with genetic and epigenetic reprogramming for solid tumors
Cancer Research·2022· 4 cited
<i>In Vivo</i> Gene Therapy for Canine SCID-X1 Using Cocal-Pseudotyped Lentiviral Vector
Human Gene Therapy·2020· 11 citedOpen Access
The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice
Journal of Biological Chemistry·2020· 58 citedOpen Access
Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction
Experimental Hematology·2020· 2 citedOpen Access
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
Nature Communications·2020· 257 citedOpen Access
Autologous, Gene-Modified Hematopoietic Stem and Progenitor Cells Repopulate the Central Nervous System with Distinct Clonal Variants
Stem Cell Reports·2019· 15 citedOpen Access
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Nature Nanotechnology·2017· 720 citedOpen Access
288. Development of Cocal Glycoprotein Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T Cells
Molecular Therapy·2016Open Access
Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells
Molecular Therapy·2016· 39 citedOpen Access
528. Generation of a Cocal Envelope Packaging Cell Line for Robust Lentiviral Gene Transfer Into Hematopoietic Stem Cells and T Cells
Molecular Therapy·2015Open Access
Intravenous injection of a foamy virus vector to correct canine SCID-X1
Blood·2014· 39 citedOpen Access
Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities
Journal of Molecular Medicine·2012· 10 citedOpen Access
Safeguarding Nonhuman Primate iPS Cells With Suicide Genes
Molecular Therapy·2011· 55 citedOpen Access
Analyse eines kapsidmodifizierten und konditionell replizierenden, onkolytischen adenoviralen Vektors als neuartige Behandlungsstrategie für Glioblastoma Multiforme
Publikationsserver (Universitat Marburg)·2010Open Access
Towards Defining An Optimal Conditioning Regimen for Stem Cell Gene Therapy In Fanconi Anemia.
Blood·2010
Efficient Generation of Nonhuman Primate Induced Pluripotent Stem Cells
Stem Cells and Development·2010· 33 citedOpen Access
Visual Graph Comparison
2009· 78 cited
Correction of Fanconi Anemia Group A in Primary Human and Murine Hematopoietic Progenitors with a Clinical Lentiviral Vector
Blood·2008
page 1 of 2Next →

Frequent Co-authors

Hans‐Peter Kiem(17), Grant D. Trobridge(9), Jennifer E. Adair(8), Brian C. Beard(6), Olivier Humbert(4), Sylvia Chien(3), Pamela S. Becker(3), Howell Moffett(2), Dnyanada Pande(2), Mark Enstrom(2), André Lieber(2), Bonan Zhong(2), Korashon L. Watts(2), Amie B. Adams(2), Phil Greenberg(2), Thomas M. Schmitt(2), Stefan Radtke(2), Xin Zhao(2), Jason Taylor(2), Xiao Wang(2)